Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Sennosides is a laxative used to treat constipation. The medication is taken by mouth or via the rectum.
- Mechanism
- Curator reviewed · 9 references
Sennoside A and B, the components of senna, are metabolized by gut bacteria into the active metabolite rheinanthrone DB13175. Rheinanthrone DB13175 appears to increase cyclooxegenase 2 (COX2) expression in macrophage cells leading to an increase in prostaglandin E2 (PGE2). This increase in PGE2 is associated with a decrease in aquaporin 3 expression in mucosal epithelial cells of the large intestine. A decrease in aquaporin 3 expression likely produces the laxative effect by restricting water reabsorption by the large intestine thereby increasing fecal water content. The exact mechanism by which rheinanthrone increases COX2 expression is unknown. Rheinanthrone DB13175 also stimulates peristalsis in the large intestine although the mechanism behind this effect is unknown. Rhein DB13174, another active metabolite is thought to excite submucosal acetylcholinergic neurons resulting in increased chloride and prostaglandin secretion. The movement of chloride ions into the large intestine would also help to draw water into the lumen.
- Primary indication
- For the over the counter treatment of constipation.Curator reviewed · 8 structured indications
- Formula / weight
- C42H38O20 · 862.746 g/mol (avg)
- First approval
- Canada, 1999
- Also known as
- Senna glycosides · Sennoside
Resolves to
IPQVTOJGNYVQEO-UHFFFAOYSA-NSMILESOCC1OC(OC2=C3C(=O)C4=C(C=C(C=C4O)C(O)=O)C(C4C5=CC=CC(OC6OC(CO)C(O)C(O)C6O)=C5C(=O)C5=C4C=C(C=C5O)C(O)=O)C3=CC=C2)C(O)C(O)C1OWhat you can answer from here — as of July 17, 2026
Which drugs share a target with Sennosides, and which of those have an active Phase 3 trial?